检索结果筛选:
文章检索列表

7 条结果, 检索条件:( ( *(AU:("Tamara Baader-Pagler")) ) )

排序: 导出:
[期刊论文]

213-OR: Antidiabetic Potential of Novel, Long-Acting Amylin Analogue ZP8396 in ZDF Rats

作者:JOLANTA SKARBALIENE ;TAMARA BAADER-PAGLER ;PER-OLOF ERIKSSON

来源:Diabetes. 2022 ;71(Supplement_1).doi:10.2337/db22-213-OR

出版社:American Diabetes Association

全文购买

[期刊论文]

The calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice

作者:Salome Gamakharia ;Christelle Le Foll ;Wolfgang Rist

来源:European Journal of Pharmacology. 2021 ;908:174352.doi:10.1016/j.ejphar.2021.174352

出版社:Elsevier BV

全文购买

[期刊论文]

SGLT6 - A pharmacological target for the treatment of obesity?

作者:Tamara Baader-Pagler ;Matthias Eckhardt ;Frank Himmelsbach

来源:Adipocyte. 2018 ;7(4):277-284.doi:10.1080/21623945.2018.1516098

出版社:Taylor & Francis Group

全文购买

[期刊论文]

Modeling energy intake and body weight effects of a long-acting amylin analogue

作者:Annika Brings ;Jens Markus Borghardt ;Jolanta Skarbaliene

来源:Journal of Pharmacokinetics and Pharmacodynamics. 2018 ;45(2):215-233.doi:10.1007/s10928-017-9557-6

出版社:Springer Nature

全文购买

[期刊论文]

723-P: The Dual Glucagon and Glucagon-Like Peptide-1 Receptor (GCGR/GLP-1R) Agonist BI 4569Reduces Body Weight in Diet-Induced Obese Mice Based on Food Intake Reduction and an Increase in Energy Expenditure

作者:TINA ZIMMERMANN ;LEO THOMAS ;TAMARA BAADER-PAGLER

来源:Diabetes. 2022 ;71(Supplement_1).doi:10.2337/db22-723-P

出版社:American Diabetes Association

全文购买

[期刊论文]

Effects of GPR139 agonism on effort expenditure for food reward in rodent models: Evidence for pro-motivational actions

作者:Alexandra Münster ;Susanne Sommer ;Diana Kúkeľová

来源:Neuropharmacology. 2022 ;213:109078.doi:10.1016/j.neuropharm.2022.109078

出版社:Elsevier BV

全文购买

[期刊论文]

BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy

作者:Tina Zimmermann ;Leo Thomas ;Tamara Baader-Pagler

来源:Molecular Metabolism. 2022 ;66:101633.doi:10.1016/j.molmet.2022.101633

出版社:Elsevier BV

开放获取

1